A first in history
On October 7, the WHO released its first guidelines addressing the sharp rise in obesity among children and adolescents, setting out how health systems and health workers can deliver timely, evidence-based and people-centered care.
According to the WHO, in 2024, 170 million children and adolescents aged 5 to 19 were living with obesity, including 70 million children aged 5 to 9 and 100 million adolescents aged 10 to 19. Obesity prevalence in this age group rose from 2% in 1990 to 8% in 2024.
Lifestyle change as the first line of defense
The guidelines draw a clear distinction between age groups. Key recommendations include:
- The WHO strongly recommends structured interventions on diet, physical activity and behavior change, delivered individually or as part of a multimodal program.
- For children under 10, the WHO does not recommend medicines, bariatric surgery or weight-loss devices.
- For adolescents aged 10 to 19, anti-obesity medicines may be considered only when a supervised lifestyle program has not achieved the desired results, while surgery may be considered under strict conditions for severe obesity.
The Indian Express called this caution welcome, especially as prescriptions of GLP-1 weight-loss drugs for children are rising fast. A study published in the journal Pediatrics found that the number of children aged 8 to 11 taking these drugs rose sharply between 2019 and 2026.
















